by Oral thin films are thin films or sheets that quickly dissolve on the tongue and deliver medicinal ingredients into the bloodstream through the oral cavity. Oral thin films offer several advantages over traditional oral dosage forms including rapid drug dissolution, bypassing first-pass liver metabolism, enhanced absorption and bioavailability, and accurate dosing. They also provide a non-invasive and convenient dosage form, which is especially beneficial for pediatric, geriatric patients and those suffering from dysphagia. The thin film gets rapidly hydrated and adheres well to the buccal membrane or gums to enable rapid absorption of drugs. Popular drugs formulated into oral thin films include migraine drugs, anti-emetics, antihistamines, treatments for pain, coughs & cold, CNS disorders and more.
The global Oral Thin Films Market is estimated to be valued at US$ 2895.55 Mn in 2023 and is expected to exhibit a CAGR of 5.1 % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the oral thin films market is the development of combination drug therapy films. Combination drug therapy oral thin films facilitate simultaneous delivery of multiple therapeutic agents through a single dosage form. This provides better clinical outcomes and improves patient compliance by reducing the number of pills taken. For instance, companies are developing oral thin films containing a mix of drugs to treat conditions like migraines, nausea, anxiety and more. Such combination therapy films are expected to gain more popularity going forward.
Porter’s Analysis
Threat of new entrants: The oral thin films market is consolidation with presence of large players. New entrants require substantial resources to develop oral thin films with varied formulations. This poses a moderate threat of new entrants.
Bargaining power of buyers: The oral thin films market has high buyer bargaining power owing to presence of many regional and private label brands increasing buyer options.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to fragmented suppliers for varied ingredients used in oral thin films. This balance supplier power over buyers.
Threat of new substitutes: The threat is low as oral thin films offer easy and convenient alternatives to conventional oral dosage forms.
Competitive rivalry: The oral thin films market witnesses high competition due to varied product offerings and manufacturing capabilities of top players.
Key Takeaways
The Global Oral Thin Films Market Size is expected to witness high growth. The global Oral Thin Films Market is estimated to be valued at US$ 2895.55 Mn in 2023 and is expected to exhibit a CAGR of 5.1 % over the forecast period 2023 to 2030.
North America dominates the market currently owing to rising consumer preference for convenient oral dosage forms over tablets and capsules. Asia Pacific is expected to be the fastest growing market for oral thin films. This can be attributed to increasing awareness and demand for oral thin films in countries like India, China and Japan. Manufacturers are expanding their footprint in these countries by collaborating with local players.
Key players operating in the oral thin films market include ANDRITZ, Thyssenkrupp, GEA Group Aktiengesellschaft, Metso, FLSmidth, Buhler Holding AG, Anivi, Carrier Vibrating Equipment, Inc., Mitchell Dryers Ltd, Yamato Sanko Co., Ltd., Kerone Engineering Solutions, Ventilex., FEECO International, Inc, GEM MACHINERY & ALLIED INDUSTRIES, Glatt GmbH, Binzen, Cadworks India Pvt. Ltd., and FEECO International, Inc. Players are focusing on new product launches, partnerships and mergers to strengthen their position in the oral thin films market.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
